Advancement in Actinic Keratosis Treatment option Driving Global Actinic Keratosis Treatment Market

The global actinic keratosis treatment market is anticipated to exhibit a CAGR of 4.7% during the forecast period (2020-2026). The rising advancement in actinic keratosis treatment options is anticipated to drive the growth of the global market. Cumulative sun exposure is the single most important cause of actinic keratosis. Lesion-specific therapy, field therapy, and PDT are the major therapies that are being used in the treatment of actinic keratosis. Cryotherapy using liquid nitrogen is a commonly used therapy for actinic keratosis treatment. This method destroys the keratinocytes through freezing, while mostly preserving important dermal structures such as blood vessels, nerves, and collagen due to their higher resistance to cold. 

Browse the full report description Global Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report by Type (Medication, Therapy, and Other), and By End-User (Hospitals & Oncology Centers, and Dermatology Clinics) Forecast period (2020-2026) at https://www.omrglobal.com/industry-reports/actinic-keratosis-treatment-market

Field therapy involves the treatment of an entire face (field) that is marked by the presence of visible actinic keratosis. It is increasingly accepted as another modality of treatment as it treats visible actinic keratosis and expanded clones of dysplastic cells at the subclinical and cellular level in that region of UV damaged skin as well. Good tolerability and efficacy, and the excellent cosmetic outcome are the major benefits of field therapy. PDT therapy involves the application of a pre-photosensitizer to the area of the skin being treated. The phototoxic reactions can cause adverse events such as erythema, stinging, itching, oedema, and exudation. This factor may restrain the adoption of this therapy for the treatment of actinic keratosis across the globe.

Market Coverage

• The market number available for – 2019-2026-
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Treatment Type, End-User
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Bausch Health Companies, Inc., Biofrontera AG, BioLineRx, Ltd., Cipher Pharmaceuticals, Inc., Galderma S.A., Hill Dermaceuticals, Inc., LEO Pharma A/S, Valeant Pharmaceuticals Inc., and so on

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected region/segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Actinic Keratosis Treatment Market Report Segment

By Type

• Medication
• Therapy
• Other

By End-User

• Hospitals & Oncology Centers
• Dermatology Clinics

Global Actinic Keratosis Treatment Market Report Segment

North America           

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa 
• Latin America